US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 178 actively recruiting studies with Wisconsin sites out of 178 registered in total. The busiest research areas in Wisconsin are Breast Cancer, Stroke, Prostate Cancer. Leading sponsors running trials in the state include Medical College of Wisconsin, University of Wisconsin, Madison, National Cancer Institute (NCI). By stage, Wisconsin trials break down as Phase 1 (21), Phase 2 (49), Phase 3 (45), Phase 4 (3).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
178
Recruiting Now
178
← Back to US Map
Top Conditions in Wisconsin
Breast Cancer (5)Stroke (5)Prostate Cancer (5)Chronic Lymphocytic Leukemia (4)Advanced Breast Cancer (3)Endometrial Cancer (3)Aphasia (3)Heart Failure (3)Pancreatic Ductal Adenocarcinoma (3)Hearing Loss (3)Multiple Myeloma (3)Phenylketonuria (PKU) (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Stroke, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT04079179 Phase 2
Recruiting
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histioc...
Condition
Langerhan's Cell Histiocytosis
Enrollment
90 pts
Location
United States
Sponsor
Carl Allen
View Trial →
NCT05687110 Phase 1
Recruiting
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients W...
Condition
Metastatic Malignant Solid Neoplasm
Enrollment
43 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05099770 Phase 3
Recruiting
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic K...
Condition
Type 2 Diabetes Mellitus
Enrollment
685 pts
Location
United States, Australia, Canada
Sponsor
Prokidney
View Trial →
NCT06285643 Phase 2
Recruiting
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
Condition
Parkinson Disease
Enrollment
127 pts
Location
United States, Germany, Poland
Sponsor
AskBio Inc
View Trial →
NCT05564390 Phase 2
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatmen...
Condition
Acute Myeloid Leukemia
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04707885 N/A
Recruiting
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
Condition
Hearing Loss, Sensorineural
Enrollment
40 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT03648918 N/A
Recruiting
Genetics Of Autoimmunity In Type I Diabetes
Condition
Type1diabetes
Enrollment
4,000 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT04510597 Phase 3
Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Wi...
Condition
Metastatic Clear Cell Renal Cell Carcinoma
Enrollment
364 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT04626791 Phase 2
Recruiting
Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Tra...
Condition
Mantle Cell Lymphoma
Enrollment
45 pts
Location
United States
Sponsor
Academic and Community Cancer
View Trial →
NCT06215118 Phase 1
Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab (PF-0686313...
Condition
Multiple Myeloma
Enrollment
87 pts
Location
United States, Australia, Canada
Sponsor
Pfizer
View Trial →
NCT03209583 N/A
Recruiting
ATrial Tachycardia PAcing Therapy in Congenital Heart
Condition
Atrial Arrhythmia
Enrollment
300 pts
Location
United States, Canada
Sponsor
Ian Law
View Trial →
NCT06807437 Phase 3
Recruiting
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Call...
Condition
Pancreatic Carcinoma
Enrollment
274 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT04558112 Phase 2
Recruiting
Improving Therapeutic Learning for PTSD
Condition
PTSD
Enrollment
120 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT04879329 Phase 2
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer Th...
Condition
Urothelial Carcinoma
Enrollment
372 pts
Location
United States, Argentina, Australia
Sponsor
Seagen, a wholly owned subsidi
View Trial →
NCT06517641 Phase 2
Recruiting
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Norma...
Condition
Severe Aplastic Anemia
Enrollment
60 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT06064877 Phase 3
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recur...
Condition
Metastatic Head-and-neck Squamous-cell Carcinoma
Enrollment
410 pts
Location
United States, Australia, Belgium
Sponsor
AVEO Pharmaceuticals, Inc.
View Trial →
NCT06027294 N/A
Recruiting
Blood Flow Regulation and Neuromuscular Function Post-Stroke
Condition
Stroke
Enrollment
40 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT06399302 N/A
Recruiting
Prospective Multicenter Research on Donor and Recipient Management Strategies to...
Condition
Lung Transplant; Complications
Enrollment
2,600 pts
Location
United States, Canada
Sponsor
Duke University
View Trial →
NCT07644702 N/A
Recruiting
WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical...
Condition
Breast Carcinoma
Enrollment
50 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT00710177 N/A
Recruiting
PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension...
Condition
Persistent Pulmonary Hypertension of the Newborn
Enrollment
200 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT06357754 N/A
Recruiting
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Br...
Condition
Non-Hodgkin Lymphoma
Enrollment
50 pts
Location
United States, Germany, Japan
Sponsor
Bristol-Myers Squibb
View Trial →
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05407636 Phase 3
Recruiting
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Condition
AMD
Enrollment
714 pts
Location
United States, Canada, France
Sponsor
AbbVie
View Trial →
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Canada
Sponsor
Merz Therapeutics GmbH
View Trial →
NCT05894967 N/A
Recruiting
Moderators and Mediators of Perceptual Learning
Condition
Cognitive Change
Enrollment
1,140 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
Page 4 of 8 — 178 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology